Hyper-IgE syndrome is a rare primary immunodeficiency of unknown etiology characterized by
recurrent infections of the skin and respiratory system, chronic
eczema, elevated total serum
IgE, and a variety of associated skeletal symptoms. Recent reports about susceptibility to pyogenic
bacterial infections and high
IgE levels in patients and animals with defects in
toll-like receptor (TLR) signaling pathways prompted us to search for TLR signaling defects as an underlying cause of
hyper-IgE syndrome. Blood samples from six patients with
hyper-IgE syndrome were analyzed for serum
cytokine levels, intracellular
cytokine production in T cells after stimulation with PMA/
ionomycin, and
cytokine production from peripheral blood mononuclear cells stimulated by TLR
ligands and bacterial products including LPS (TLR4),
peptidoglycan (TLR2), PolyIC (TLR3), R848 (TLR7/8), CpG-A, and CpG-B (TLR9),
zymosan and heat killed Listeria monocytogenes. All results were compared to data from healthy controls. A reduction in IFN-gamma,
IL-2, and
TNF-alpha producing T cells after PMA stimulation suggested a reduced inflammatory T cell response in patients with
hyper-IgE syndrome. Increased serum levels of
IL-5 indicated a concomitant Th2 shift. However, normal production of
cytokines (TNF-alpha, IL-6, IL-10, IFN-alpha, IP-10) and upregulation of CD86 on B cells and monocytes after TLR stimulation made a defect in TLR signaling pathways highly unlikely. In summary, our data confirmed an imbalance in T cell responses of patients with
hyper-IgE syndrome as previously described but showed no indication for an underlying defect in
toll-like receptor signaling.